Author

Philip Jonsson

Celsius Therapeutics (United States)ORCID 0000-0002-1537-0624Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Antonio Finelli· 1 shared Bernd BodenmilleriD· 1 shared Cristina PeñarandaiD· 1 shared Daniel Stueckmann· 1 shared Dominik DeniffeliD· 1 shared Fred P. DavisiD· 1 shared Gary D. BaderiD· 1 shared Gromoslaw Aleksander SmoleniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antonio Finelli

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 20, 2026

Multimodal cell communication networks nominate immunotherapies for RCC subgroups with discrete T cell recruitment or expansion

Jennifer Q. Pfeil, Shirley Hui, Daniel Stueckmann…·Keith A. Lawson

The paper integrates multi-modal data to identify immune subgroups in RCC and suggests immunotherapy strategies based on distinct T cell communication networks.

DOI 10.64898/2026.08.17.744644

humanscRNA-seq

𝕏 PostBluesky